KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $105M | +2.9% |
| Gross profit | $0 | — |
| Operating income | −$350M | — |
| Net income | −$300M | — |
| EPS | −$3.24 | — |
| Free cash flow | −$238M | — |
Kymera Therapeutics, Inc.
$107.39−2.73 (−2.48%)Close Oct 2, 2026
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $105M | +2.9% |
| Gross profit | $0 | — |
| Operating income | −$350M | — |
| Net income | −$300M | — |
| EPS | −$3.24 | — |
| Free cash flow | −$238M | — |